ArticleHaematologica2024

Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.

Shannon L Carey-Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.